| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Coagulation factor XI-containing product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Coagulation factor XIII 1250 unit powder for solution for injection vial |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Coagulation factor XI only product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing only coagulation factor IX in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing von Willebrand factor in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing only thrombin in cutaneous dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Albutrepenonacog alfa only product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing only porcine factor VIII in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing thrombin in cutaneous dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Moroctocog alfa-containing product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Nonacog alfa only product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing recombinant coagulation factor IX in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Bovine thrombin only product in cutaneous dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Hemostatic agent |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Albutrepenonacog alfa-containing product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing coagulation factor VIIa in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Efmoroctocog alfa-containing product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing only efmoroctocog alfa in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Moroctocog alfa only product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Coagulation factor XIII-containing product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Octocog alfa only product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Octocog alfa-containing product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Nonacog beta pegol-containing product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing only coagulation factor XIII in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing bovine thrombin in cutaneous dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing human fibrinogen in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing coagulation factor IX in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing precisely coagulation factor XIII 250 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing only human fibrinogen in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Coagulation factor Xa only product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing nonacog alfa in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Coagulation factor VIIa only product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Coagulation factor Xa-containing product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing only nonacog beta pegol in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Porcine factor VIII-containing product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| eltrombopag 50 milligram, oral tablett |
Plays role |
False |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Tranexamic acid-containing product in oral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Tranexamic acid-containing product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Etamsylate-containing product in oral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Desmopressin-containing product in nasal dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Desmopressin acetate 10 microgram/actuation nasal spray |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing only etamsylate in oral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Gelatin-containing product in cutaneous dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing aminocaproic acid in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Gelatin only product in cutaneous dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing precisely desmopressin acetate 100 microgram/1 milliliter conventional release nasal solution (clinical drug) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing romiplostim in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Aminocaproic acid-containing product in oral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Desmopressin only product in nasal dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Aminocaproic acid 500 mg oral tablet |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing only recombinant antihemophilic factor pegylated liposome in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing only desmopressin in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing only aminocaproic acid in oral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing only aminocaproic acid in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Tranexamic acid 650 mg oral tablet |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing oxidized cellulose in cutaneous dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing only oxidized cellulose in cutaneous dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing eltrombopag in oral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing anti-inhibitor coagulant complex in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing only anti-inhibitor coagulant complex in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing recombinant antihemophilic factor pegylated liposome in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| eltrombopag 25 milligram, oral tablett |
Plays role |
False |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Romiplostim only product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Etamsylate 500 mg oral tablet |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Aprotinin-containing product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Desmopressin-containing product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| eltrombopag 75 milligram, oral tablett |
Plays role |
False |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Emicizumab-containing product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Tranexamic acid 500 mg oral tablet |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing only aprotinin in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Carbazochrome-containing product in oral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Carbazochrome only product in oral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing precisely romiplostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Eltrombopag only product in oral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing only tranexamic acid in oral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Tranexamic acid only product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing only emicizumab in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Desmopressin acetate 4 microgram/mL solution for injection |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Tranexamic acid 100 mg/mL solution for injection |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing andexanet alfa in parenteral dose form (medicinal product form) |
Plays role |
False |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing only andexanet alfa in parenteral dose form (medicinal product form) |
Plays role |
False |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing precisely desmopressin acetate 150 microgram/1 actuation conventional release nasal spray (clinical drug) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Romiplostim 500 microgram powder for solution for injection vial |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Aminocaproic acid 250 mg/mL oral solution |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Aprotinin 1.4 mg/mL solution for injection |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing only recombinant coagulation factor IX in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing only von Willebrand factor in parenteral dose form (medicinal product form) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| nonakog alfa 250 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
Plays role |
False |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| nonakog alfa 1 000 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
Plays role |
False |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| nonakog alfa 500 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
Plays role |
False |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Coagulation factor VIII 1000 unit and von Willebrand factor 2500 unit powder for solution for injection vial |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Coagulation factor VIII 500 unit and von Willebrand factor 1250 unit powder for solution for injection vial |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Coagulation factor VIII- and von Willebrand factor-containing product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Coagulation factor VIII and von Willebrand factor only product in parenteral dose form |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| oktokog alfa 250 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
Plays role |
False |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| oktokog alfa 500 IE/injektionsflaska, frystorkat pulver till injicerbar lösning |
Plays role |
False |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| desmopressinacetat 100 mikrog/ml, näsdroppar, lösning |
Plays role |
False |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Desmopressin acetate 100 microgram/mL nasal drops |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing precisely emicizumab 30 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Emicizumab 150 mg/mL solution for injection |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|
| Product containing precisely eltrombopag (as eltrombopag olamine) 25 milligram/1 each conventional release oral tablet (clinical drug) |
Plays role |
True |
Hemostatic therapeutic role (role) |
Inferred relationship |
Some |
|